Royal Brompton's cardiac expertise was profiled in a leading European cardiology journal this year and was described as a "centre of excellence" with " stand-out" research.
The September 2017 edition of the European Heart Journal, published by the European Society of Cardiology and one of the leading cardiology publications in the world, featured a profile of Royal Brompton’s unit.
The report describes the hospital as a centre that “prides itself on leading innovative research whilst providing first class care to patients.”
Highlighting that “research, innovation and education have been constant themes” at Royal Brompton since it was founded in 1841, the journal explained that the Trust produces more highly cited publications about respiratory and cardiovascular medicine than any other NHS trust in England.
Research highlighted in the article includes the CardioMems system, where a microchip is placed in the pulmonary artery for patients with heart failure to enable remote monitoring, and, in collaboration with respiratory specialists at the hospital, new ventilation and mask technologies for the treatment of sleep apnoea and heart failure.
While highlighting the hospital’s “world-class research facilities” and congenital heart disease as a “stand-out area of research”, patient-centred care is identified as the Trust’s focus.
Consultant cardiologist Professor Kim Fox commented: "Everything we do at Royal Brompton and Harefield is based on our patients. Our research is patient-focused and we believe we can give the best care to our patients by having a high-profile interaction between our clinical and research colleagues."